Checkpoint inhibitor blockade has also proven effective in the treatment of cancers such as melanoma (Hodi et al., 2003, Hodi et al., 2010) and in combined therapy with anti-CTLA-4 (Topalian et al., 2015, Wolchok et al., 2013). The gene discussed is CTLA4; the disease is cancer.